Group medical visits in the follow-up of women with a <it>BRCA </it>mutation: design of a randomized controlled trial
<p>Abstract</p> <p>Background</p> <p><it>BRCA </it>mutation carriers have a 40-80% life-time risk of developing breast cancer. They may opt for yearly breast cancer surveillance or for prophylactic mastectomy. Both options show increased survival rates. It i...
Saved in:
Main Authors: | Hoogerbrugge Nicoline (Author), Prins Judith B (Author), Visser Annemiek (Author), van Laarhoven Hanneke WM (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life
by: Marieke Arts-de Jong, et al.
Published: (2018) -
DNA-testing for <it>BRCA1/2</it> prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct
by: Sie Aisha S, et al.
Published: (2012) -
BRCA1 and BRCA2 Mutations Diagnostic and Therapeutic Implications
Published: (2023) -
BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
by: Tarinee Manchana, et al.
Published: (2020) -
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
by: Avantika Lal, et al.
Published: (2019)